The North America Helicobacter Pylori Diagnostics Market would witness market growth of 4.8% CAGR during the forecast period (2023-2030).
Helicobacter pylori (H. pylori) is a bacterium that infects the stomach and is linked to several gastrointestinal conditions, including gastritis and peptic ulcer disease. The diagnosis of H. pylori infection can be made using various techniques, including a breath test, a stool antigen test, and a quick urease test. Helicobacter pylori, a kind of bacteria, can infect the small intestine and the stomach. Gastritis (inflammation of the stomach lining), peptic ulcers (sores in the stomach or duodenum), and in rare instances, stomach cancer are all brought on by H. pylori. Infection with H. pylori frequently causes stomach pain, nausea, vomiting, appetite loss, and weight loss.
These infections are most common in developing nations. Hundreds of millions experience peptic ulcers at some point in their lives, and tens of millions of those may eventually develop stomach cancer. Direct contact between family members, tainted water, and infected food are all potential ways that H. pylori might spread. It is essential to take quick action against this bacterial infection and establish a plan to avoid it because the high frequency of infection occurs primarily in developing nations and because the test-and-treat technique places a tremendous economic burden on many of these countries.
In 2020, there were reported 9126 cases of infectious syphilis, for a rate of 24 per 100,000 people. In the last five years (2016 to 2020), the rate of infectious syphilis among females has increased by 740 percent, while the rate among males has increased by 70 percent. Nationally, infectious syphilis has increased by 124% from 2016 to 2020. In almost every province and territory (except New Brunswick and Nunavut), syphilis infection rates have increased. As helicobacter pylori diagnostics are also recommended for diagnosing syphilis, their growing cases are expected to increase the utilization of helicobacter pylori diagnostics methods, thus aiding the market growth in North America.
The US market dominated the North America Helicobacter Pylori Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $215.1 Million by 2030. The Canada market is poised to grow at a CAGR of 7.2% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 6.3% during (2023 - 2030).
Based on Test Type, the market is segmented into Non-invasive and Invasive. Based on End User, the market is segmented into Diagnostics Laboratories, Hospitals, and Others. Based on Method, the market is segmented into Laboratory Based Test and Point of Care Test. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Helicobacter Pylori Diagnostics Market is Projected to reach USD 805.9 Million by 2030, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardinal Health, Inc., Biohit Oyj, Abbott Laboratories, Quidel Corporation, Gulf Coast Scientific, Inc. (Gulf Coast Medical Center), Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.), Avanos Medical, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. and F. Hoffmann-La Roche Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Test Type
By End User
- Diagnostics Laboratories
- Hospitals
- Others
By Method
- Laboratory Based Test
- Point of Care Test
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Cardinal Health, Inc.
- Biohit Oyj
- Abbott Laboratories
- Quidel Corporation
- Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
- Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
- Avanos Medical, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- F.Hoffmann-La Roche Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Helicobacter Pylori Diagnostics Market, by Test Type
1.4.2 North America Helicobacter Pylori Diagnostics Market, by End User
1.4.3 North America Helicobacter Pylori Diagnostics Market, by Method
1.4.4 North America Helicobacter Pylori Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Helicobacter Pylori Diagnostics Market by Test Type
3.1 North America Non-invasive Market by Country
3.2 North America Invasive Market by Country
Chapter 4. North America Helicobacter Pylori Diagnostics Market by End User
4.1 North America Diagnostics Laboratories Market by Country
4.2 North America Hospitals Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Helicobacter Pylori Diagnostics Market by Method
5.1 North America Laboratory Based Test Market by Country
5.2 North America Point of Care Test Market by Country
Chapter 6. North America Helicobacter Pylori Diagnostics Market by Country
6.1 US Helicobacter Pylori Diagnostics Market
6.1.1 US Helicobacter Pylori Diagnostics Market by Test Type
6.1.2 US Helicobacter Pylori Diagnostics Market by End User
6.1.3 US Helicobacter Pylori Diagnostics Market by Method
6.2 Canada Helicobacter Pylori Diagnostics Market
6.2.1 Canada Helicobacter Pylori Diagnostics Market by Test Type
6.2.2 Canada Helicobacter Pylori Diagnostics Market by End User
6.2.3 Canada Helicobacter Pylori Diagnostics Market by Method
6.3 Mexico Helicobacter Pylori Diagnostics Market
6.3.1 Mexico Helicobacter Pylori Diagnostics Market by Test Type
6.3.2 Mexico Helicobacter Pylori Diagnostics Market by End User
6.3.3 Mexico Helicobacter Pylori Diagnostics Market by Method
6.4 Rest of North America Helicobacter Pylori Diagnostics Market
6.4.1 Rest of North America Helicobacter Pylori Diagnostics Market by Test Type
6.4.2 Rest of North America Helicobacter Pylori Diagnostics Market by End User
6.4.3 Rest of North America Helicobacter Pylori Diagnostics Market by Method
Chapter 7. Company Profiles
7.1 Biohit Oyj
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.2 Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
7.2.1 Company Overview
7.3 Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Recent strategies and developments:
7.3.3.1 Acquisition and Mergers:
7.4 Avanos Medical, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Thermo Fisher Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 F. Hoffmann-La Roche Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Quidel Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. Bio-Rad laboratories, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
TABLE 1 North America Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 2 North America Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 3 North America Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 4 North America Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 5 North America Non-invasive Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Non-invasive Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Invasive Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Invasive Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 10 North America Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 11 North America Diagnostics Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Diagnostics Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 18 North America Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 19 North America Laboratory Based Test Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Laboratory Based Test Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Point of Care Test Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Point of Care Test Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Helicobacter Pylori Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Helicobacter Pylori Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 25 US Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 26 US Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 27 US Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 28 US Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 29 US Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 30 US Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 31 US Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 32 US Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 33 Canada Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 34 Canada Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 35 Canada Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 36 Canada Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 37 Canada Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 38 Canada Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 39 Canada Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 40 Canada Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 41 Mexico Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 42 Mexico Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 43 Mexico Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 44 Mexico Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 45 Mexico Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 46 Mexico Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 47 Mexico Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 48 Mexico Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 49 Rest of North America Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 50 Rest of North America Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 51 Rest of North America Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 52 Rest of North America Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 53 Rest of North America Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 54 Rest of North America Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 55 Rest of North America Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 56 Rest of North America Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 57 Key Information – Biohit Oyj
TABLE 58 Key Information – Gulf Coast Scientific, Inc.
TABLE 59 Key Information – Meridian Bioscience, Inc.
TABLE 60 Key Information – Avanos Medical, Inc.
TABLE 61 Key Information – Abbott Laboratories
TABLE 62 Key Information – Thermo Fisher Scientific, Inc.
TABLE 63 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 64 key information – Quidel Corporation
TABLE 65 key information – Cardinal Health, Inc.
TABLE 66 Key Information – Bio-Rad Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Helicobacter Pylori Diagnostics Market share by Test Type, 2022
FIG 3 North America Helicobacter Pylori Diagnostics Market share by Test Type, 2030
FIG 4 North America Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2030, USD Million
FIG 5 North America Helicobacter Pylori Diagnostics Market share by End User, 2022
FIG 6 North America Helicobacter Pylori Diagnostics Market share by End User, 2030
FIG 7 North America Helicobacter Pylori Diagnostics Market by End User, 2019 - 2030, USD Million
FIG 8 North America Helicobacter Pylori Diagnostics Market share by Method, 2022
FIG 9 North America Helicobacter Pylori Diagnostics Market share by Method, 2030
FIG 10 North America Helicobacter Pylori Diagnostics Market by Method, 2019 - 2030, USD Million
FIG 11 North America Helicobacter Pylori Diagnostics Market share by Country, 2022
FIG 12 North America Helicobacter Pylori Diagnostics Market share by Country, 2030
FIG 13 North America Helicobacter Pylori Diagnostics Market by Country, 2019 - 2030, USD Million
FIG 14 Swot analysis: Abbott laboratories
FIG 15 Swot analysis: thermo fisher scientific, inc.